Global OTC Anti-Infective Products Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global OTC Anti-Infective Products Market
Anti-infectives are medicines that work to prevent or treat infections.

Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.

Due to the COVID-19 pandemic, the global OTC Anti-Infective Products market size is estimated to be worth US$ 13810 million in 2022 and is forecast to a readjusted size of US$ 16880 million by 2028 with a CAGR of 3.4% during the review period. Fully considering the economic change by this health crisis, Antifungal accounting for % of the OTC Anti-Infective Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Antifungal

Antibacterial

Antiviral

Antiseptics

Others

Segment by Sales Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the OTC Anti-Infective Products market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Bayer

GSK

Teva

Johnson & Johnson

NOVARTIS

MYLAN

Sun Pharma

CR SANJIU

Cipla

Lingrui

1 Study Coverage
1.1 OTC Anti-Infective Products Product Introduction

1.2 Market by Type

1.2.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Antifungal

1.2.3 Antibacterial

1.2.4 Antiviral

1.2.5 Antiseptics

1.2.6 Others

1.3 Market by Sales Channel

1.3.1 Global OTC Anti-Infective Products Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global OTC Anti-Infective Products Sales Estimates and Forecasts 2017-2028

2.2 Global OTC Anti-Infective Products Revenue Estimates and Forecasts 2017-2028

2.3 Global OTC Anti-Infective Products Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global OTC Anti-Infective Products Sales by Region

2.4.1 Global OTC Anti-Infective Products Sales by Region (2017-2022)

2.4.2 Global Sales OTC Anti-Infective Products by Region (2023-2028)

2.5 Global OTC Anti-Infective Products Revenue by Region

2.5.1 Global OTC Anti-Infective Products Revenue by Region (2017-2022)

2.5.2 Global OTC Anti-Infective Products Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global OTC Anti-Infective Products Sales by Manufacturers

3.1.1 Global Top OTC Anti-Infective Products Manufacturers by Sales (2017-2022)

3.1.2 Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of OTC Anti-Infective Products in 2021

3.2 Global OTC Anti-Infective Products Revenue by Manufacturers

3.2.1 Global OTC Anti-Infective Products Revenue by Manufacturers (2017-2022)

3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2021

3.3 Global OTC Anti-Infective Products Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global OTC Anti-Infective Products Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global OTC Anti-Infective Products Sales by Type

4.1.1 Global OTC Anti-Infective Products Historical Sales by Type (2017-2022)

4.1.2 Global OTC Anti-Infective Products Forecasted Sales by Type (2023-2028)

4.1.3 Global OTC Anti-Infective Products Sales Market Share by Type (2017-2028)

4.2 Global OTC Anti-Infective Products Revenue by Type

4.2.1 Global OTC Anti-Infective Products Historical Revenue by Type (2017-2022)

4.2.2 Global OTC Anti-Infective Products Forecasted Revenue by Type (2023-2028)

4.2.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2017-2028)

4.3 Global OTC Anti-Infective Products Price by Type

4.3.1 Global OTC Anti-Infective Products Price by Type (2017-2022)

4.3.2 Global OTC Anti-Infective Products Price Forecast by Type (2023-2028)

5 Market Size by Sales Channel

5.1 Global OTC Anti-Infective Products Sales by Sales Channel

5.1.1 Global OTC Anti-Infective Products Historical Sales by Sales Channel (2017-2022)

5.1.2 Global OTC Anti-Infective Products Forecasted Sales by Sales Channel (2023-2028)

5.1.3 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)

5.2 Global OTC Anti-Infective Products Revenue by Sales Channel

5.2.1 Global OTC Anti-Infective Products Historical Revenue by Sales Channel (2017-2022)

5.2.2 Global OTC Anti-Infective Products Forecasted Revenue by Sales Channel (2023-2028)

5.2.3 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2017-2028)

5.3 Global OTC Anti-Infective Products Price by Sales Channel

5.3.1 Global OTC Anti-Infective Products Price by Sales Channel (2017-2022)

5.3.2 Global OTC Anti-Infective Products Price Forecast by Sales Channel (2023-2028)

6 North America

6.1 North America OTC Anti-Infective Products Market Size by Type

6.1.1 North America OTC Anti-Infective Products Sales by Type (2017-2028)

6.1.2 North America OTC Anti-Infective Products Revenue by Type (2017-2028)

6.2 North America OTC Anti-Infective Products Market Size by Sales Channel

6.2.1 North America OTC Anti-Infective Products Sales by Sales Channel (2017-2028)

6.2.2 North America OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)

6.3 North America OTC Anti-Infective Products Market Size by Country

6.3.1 North America OTC Anti-Infective Products Sales by Country (2017-2028)

6.3.2 North America OTC Anti-Infective Products Revenue by Country (2017-2028)

6.3.3 United States

6.3.4 Canada

7 Europe

7.1 Europe OTC Anti-Infective Products Market Size by Type

7.1.1 Europe OTC Anti-Infective Products Sales by Type (2017-2028)

7.1.2 Europe OTC Anti-Infective Products Revenue by Type (2017-2028)

7.2 Europe OTC Anti-Infective Products Market Size by Sales Channel

7.2.1 Europe OTC Anti-Infective Products Sales by Sales Channel (2017-2028)

7.2.2 Europe OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)

7.3 Europe OTC Anti-Infective Products Market Size by Country

7.3.1 Europe OTC Anti-Infective Products Sales by Country (2017-2028)

7.3.2 Europe OTC Anti-Infective Products Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific OTC Anti-Infective Products Market Size by Type

8.1.1 Asia Pacific OTC Anti-Infective Products Sales by Type (2017-2028)

8.1.2 Asia Pacific OTC Anti-Infective Products Revenue by Type (2017-2028)

8.2 Asia Pacific OTC Anti-Infective Products Market Size by Sales Channel

8.2.1 Asia Pacific OTC Anti-Infective Products Sales by Sales Channel (2017-2028)

8.2.2 Asia Pacific OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)

8.3 Asia Pacific OTC Anti-Infective Products Market Size by Region

8.3.1 Asia Pacific OTC Anti-Infective Products Sales by Region (2017-2028)

8.3.2 Asia Pacific OTC Anti-Infective Products Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America OTC Anti-Infective Products Market Size by Type

9.1.1 Latin America OTC Anti-Infective Products Sales by Type (2017-2028)

9.1.2 Latin America OTC Anti-Infective Products Revenue by Type (2017-2028)

9.2 Latin America OTC Anti-Infective Products Market Size by Sales Channel

9.2.1 Latin America OTC Anti-Infective Products Sales by Sales Channel (2017-2028)

9.2.2 Latin America OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)

9.3 Latin America OTC Anti-Infective Products Market Size by Country

9.3.1 Latin America OTC Anti-Infective Products Sales by Country (2017-2028)

9.3.2 Latin America OTC Anti-Infective Products Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa OTC Anti-Infective Products Market Size by Type

10.1.1 Middle East and Africa OTC Anti-Infective Products Sales by Type (2017-2028)

10.1.2 Middle East and Africa OTC Anti-Infective Products Revenue by Type (2017-2028)

10.2 Middle East and Africa OTC Anti-Infective Products Market Size by Sales Channel

10.2.1 Middle East and Africa OTC Anti-Infective Products Sales by Sales Channel (2017-2028)

10.2.2 Middle East and Africa OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)

10.3 Middle East and Africa OTC Anti-Infective Products Market Size by Country

10.3.1 Middle East and Africa OTC Anti-Infective Products Sales by Country (2017-2028)

10.3.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Bayer

11.1.1 Bayer Corporation Information

11.1.2 Bayer Overview

11.1.3 Bayer OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Bayer OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Bayer Recent Developments

11.2 GSK

11.2.1 GSK Corporation Information

11.2.2 GSK Overview

11.2.3 GSK OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 GSK OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GSK Recent Developments

11.3 Teva

11.3.1 Teva Corporation Information

11.3.2 Teva Overview

11.3.3 Teva OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Teva OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Teva Recent Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Corporation Information

11.4.2 Johnson & Johnson Overview

11.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Johnson & Johnson OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Johnson & Johnson Recent Developments

11.5 NOVARTIS

11.5.1 NOVARTIS Corporation Information

11.5.2 NOVARTIS Overview

11.5.3 NOVARTIS OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 NOVARTIS OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 NOVARTIS Recent Developments

11.6 MYLAN

11.6.1 MYLAN Corporation Information

11.6.2 MYLAN Overview

11.6.3 MYLAN OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 MYLAN OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 MYLAN Recent Developments

11.7 Sun Pharma

11.7.1 Sun Pharma Corporation Information

11.7.2 Sun Pharma Overview

11.7.3 Sun Pharma OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Sun Pharma OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Sun Pharma Recent Developments

11.8 CR SANJIU

11.8.1 CR SANJIU Corporation Information

11.8.2 CR SANJIU Overview

11.8.3 CR SANJIU OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 CR SANJIU OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 CR SANJIU Recent Developments

11.9 Cipla

11.9.1 Cipla Corporation Information

11.9.2 Cipla Overview

11.9.3 Cipla OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Cipla OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Cipla Recent Developments

11.10 Lingrui

11.10.1 Lingrui Corporation Information

11.10.2 Lingrui Overview

11.10.3 Lingrui OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Lingrui OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Lingrui Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 OTC Anti-Infective Products Industry Chain Analysis

12.2 OTC Anti-Infective Products Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 OTC Anti-Infective Products Production Mode & Process

12.4 OTC Anti-Infective Products Sales and Marketing

12.4.1 OTC Anti-Infective Products Sales Channels

12.4.2 OTC Anti-Infective Products Distributors

12.5 OTC Anti-Infective Products Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 OTC Anti-Infective Products Industry Trends

13.2 OTC Anti-Infective Products Market Drivers

13.3 OTC Anti-Infective Products Market Challenges

13.4 OTC Anti-Infective Products Market Restraints

14 Key Findings in The Global OTC Anti-Infective Products Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer